Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation.
Fu Q, Bustamante-Gomez NC, Reyes-Pardo H, Gubrij I, Escalona-Vargas D, Thostenson JD, Palmieri M, Goellner JJ, Nookaew I, Barnes CL, Stambough JB, Ambrogini E, O'Brien CA.
Fu Q, et al. Among authors: stambough jb.
JCI Insight. 2023 Sep 22;8(18):e167790. doi: 10.1172/jci.insight.167790.
JCI Insight. 2023.
PMID: 37581932
Free PMC article.